Medscape 2050
In honor of Medscape’s 30th anniversary, we’ve challenged some of the top minds in medicine and science to imagine medicine in the year 2050.
Related Articles
SGLT2 Inhibitors: From Glucose-Lowering to Cardio Protection
Initially used for blood glucose control, the medications reduce cardiovascular events and mitigate heart failure hospitalization, regardless of diabetes status.
Small Earwax Sample, Big Diagnostic Clues
A novel cerumen assay called the cerumenogram differentiates healthy and cancerous profiles with remarkable accuracy from tiny wax samples.
AI Meets Frailty: Rethinking Hematology in Older Patients
Hematologists treating older patients face complex challenges, from remembering drug interactions to tailoring individualized treatment pathways. Can AI help?
Regulatory Challenges for Nurse Practitioners and Physician Assistants: Changes Are Constant
Practitioners in each profession detail the speed of regulatory challenges and changes, emphasize the importance of keeping up, and offer advice on how to do…
Experts Suggest NHS Heart Risk Checks From Age 25
Starting NHS heart health assessments at 25, not 40, could help tackle soaring lifetime cardiovascular risk and reduce preventable early deaths.
Probiotics, Prebiotics Tied to Decreased Depression, Anxiety
The use vs nonuse of probiotics and prebiotics, alone or combined, are linked to a greater decrease in depression and anxiety symptoms, new research shows.
FDA Approves Triple Rx for Hypertension
The three-drug pill combines telmisartan, amlodipine, and indapamide.
Nurse Practitioner Identity and Recognition Key to Success
NPs are increasingly important to the US healthcare system, but getting the respect and recognition that should come with that role is still a challenge.
Add-On Niraparib May Slow Hormone-Sensitive Metastatic Prostate Cancer
Adding Niraparib to standard therapy slows tumor growth and time to symptomatic progression in men with metastatic hormone sensitive prostate cancer.
AI and Home Dialysis: From Prediction to Personalization
Artificial intelligence and telemedicine are transforming dialysis care, improving predictions, expanding access, and enabling patient-centered home therapies.